InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,633.91
(
1.02%
)
US TECH 100
20,118.40
(
0.00%
)
Dow Jones
39,721.36
(
1.09%
)
Brent Oil
85.19
(
0.16%
)
Bitcoin
58,137.89
(
0.66%
)
Post# of 252557
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 831
Posts 120016
Boards Moderated 17
Alias Born 09/05/2002

DewDiligence

Member Level

Re: None

Wednesday, 12/16/2020 8:33:31 PM

Wednesday, December 16, 2020 8:33:31 PM

Post# of 252557
Interesting…

https://www.prnewswire.com/news-releases/prep-biopharm-limited-announces-successful-completion-of-prep-001-toxicology-study-enabling-phase-2b-field-study-of-prep-001-against-all-respiratory-viruses-301194520.html

PrEP-001 is neither a vaccine nor an antiviral. Rather, it is a synthetic RNA 'viral mimic' that stimulates the body's pan-viral innate immune response locally in the upper respiratory tract. Administered via a once daily nasal spray it leverages the innate immune system to create an antiviral environment to stop invading respiratory viruses.

PrEP Biopharma Ltd is a private company.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up